253 related articles for article (PubMed ID: 10450)
21. Optimising urinary catecholamine metabolite diagnostics for neuroblastoma.
Matser YAH; Verly IRN; van der Ham M; de Sain-van der Velden MGM; Verhoeven-Duif NM; Ash S; Cangemi G; Barco S; Popovic MB; van Kuilenburg ABP; Tytgat GAM;
Pediatr Blood Cancer; 2023 Jun; 70(6):e30289. PubMed ID: 37010353
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of plasma 3,4-dihydroxyphenylacetic acid (DOPAC) and plasma 3,4-dihydroxyphenylalanine (DOPA) as tumor markers in children with neuroblastoma.
Eldrup E; Clausen N; Scherling B; Schmiegelow K
Scand J Clin Lab Invest; 2001; 61(6):479-90. PubMed ID: 11681538
[TBL] [Abstract][Full Text] [Related]
23. Catecholamines and their metabolites in the brain and urine of rats with experimental Parkinson's disease.
Chekhonin VP; Baklaushev VP; Kogan BM; Savchenko EA; Lebedev SV; Man'kovskaya IV; Filatova TS; Yusupova IU; Dmitrieva TB
Bull Exp Biol Med; 2000 Aug; 130(8):805-9. PubMed ID: 11177250
[TBL] [Abstract][Full Text] [Related]
24. The influence of total sleep deprivation on urinary excretion of catecholamine metabolites in major depression.
Müller HU; Riemann D; Berger M; Müller WE
Acta Psychiatr Scand; 1993 Jul; 88(1):16-20. PubMed ID: 8396844
[TBL] [Abstract][Full Text] [Related]
25. Urine catecholamine levels as diagnostic markers for neuroblastoma in a defined population: implications for ophthalmic practice.
Smith SJ; Diehl NN; Smith BD; Mohney BG
Eye (Lond); 2010 Dec; 24(12):1792-6. PubMed ID: 20865029
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of catecholamine biosynthesis by carbidopa and metyrosine in neuroblastoma.
Anton AH; Crumrine RS; Stern RC; Izant RJ
Pediatr Pharmacol (New York); 1983; 3(2):107-17. PubMed ID: 6425794
[TBL] [Abstract][Full Text] [Related]
27. Catecholamines profiles at diagnosis: Increased diagnostic sensitivity and correlation with biological and clinical features in neuroblastoma patients.
Verly IR; van Kuilenburg AB; Abeling NG; Goorden SM; Fiocco M; Vaz FM; van Noesel MM; Zwaan CM; Kaspers GL; Merks JH; Caron HN; Tytgat GA
Eur J Cancer; 2017 Feb; 72():235-243. PubMed ID: 28061374
[TBL] [Abstract][Full Text] [Related]
28. Plasma dopa and catecholamines in the diagnosis and follow-up of children with neuroblastoma.
Alvarado CS; Faraj BA; Kim TH; Camp VM; Bain RP; Ragab AH
Am J Pediatr Hematol Oncol; 1985; 7(3):221-7. PubMed ID: 3934994
[TBL] [Abstract][Full Text] [Related]
29. Excretion of octopamine metabolites in neuroblastoma.
Couch MW; Greer DM; Williams CM
Clin Chim Acta; 1986 Jul; 158(1):109-14. PubMed ID: 3091293
[TBL] [Abstract][Full Text] [Related]
30. Olive ingestion causing a false suspicion of relapsed neuroblastoma: A case of "oliveblastoma?".
Flynn N; LeFebvre A; Messahel B; Hogg SL
Pediatr Blood Cancer; 2018 Oct; 65(10):e27248. PubMed ID: 29923309
[TBL] [Abstract][Full Text] [Related]
31. Value of random urinary homovanillic acid and vanillylmandelic acid levels in the diagnosis and management of patients with neuroblastoma: comparison with 24-hour urine collections.
Tuchman M; Morris CL; Ramnaraine ML; Bowers LD; Krivit W
Pediatrics; 1985 Feb; 75(2):324-8. PubMed ID: 3969335
[TBL] [Abstract][Full Text] [Related]
32. Three years of experience with random urinary homovanillic and vanillylmandelic acid levels in the diagnosis of neuroblastoma.
Tuchman M; Ramnaraine ML; Woods WG; Krivit W
Pediatrics; 1987 Feb; 79(2):203-5. PubMed ID: 3808793
[TBL] [Abstract][Full Text] [Related]
33. Dopa, catecholamines and their metabolites in essential hypertension.
Januszewicz W; Wocial B
Clin Sci Mol Med Suppl; 1975 Jun; 2():295s-298s. PubMed ID: 1077780
[TBL] [Abstract][Full Text] [Related]
34. Hormonal activity may predict aggressive behavior in neuroblastoma.
Zambrano E; Reyes-Múgica M
Pediatr Dev Pathol; 2002; 5(2):190-9. PubMed ID: 11910515
[TBL] [Abstract][Full Text] [Related]
35. Catecholamine metabolites in ganglioneuroma.
Lucas K; Gula MJ; Knisely AS; Virgi MA; Wollman M; Blatt J
Med Pediatr Oncol; 1994; 22(4):240-3. PubMed ID: 8107654
[TBL] [Abstract][Full Text] [Related]
36. Plasma catecholamines and urinary excretion of their main metabolites in three models of portal hypertension.
Rodríguez-Puyol D; Alsasua A; Santos JC; Blanchart A; López-Novoa JM
Clin Physiol Biochem; 1988; 6(6):301-9. PubMed ID: 3208482
[TBL] [Abstract][Full Text] [Related]
37. Determination of serum catecholamine metabolites in neuroblastoma by high performance liquid chromatography with electrochemical detection.
Tang QM; Xu XR; Shi YQ; Jin BX
Biomed Chromatogr; 1986 Feb; 1(1):7-11. PubMed ID: 3506818
[TBL] [Abstract][Full Text] [Related]
38. "Total" acidic metabolites of catecholamines in urine as determined by hydrolysis with hydriodic acid and liquid chromatography: application to patients with neuroblastoma and melanoma.
Ito S; Kato T; Maruta K; Jimbow K; Fujita K
Clin Chem; 1985 Jul; 31(7):1185-8. PubMed ID: 4006189
[TBL] [Abstract][Full Text] [Related]
39. Catecholamine metabolism in neuroblastoma: kinetics of conversion of 3H-3-methoxy-4-hydroxyphenylglycol to 3H-3-methoxy-4-hydroxymandelic acid.
LaBrosse EH
J Clin Endocrinol Metab; 1970 May; 30(5):580-9. PubMed ID: 4910525
[No Abstract] [Full Text] [Related]
40. Interchangeability between 24-hour collection and single spot urines for vanillylmandelic and homovanillic acid levels in the diagnosis of neuroblastoma.
Cangemi G; Barco S; Reggiardo G; Viscardi E; Di Cataldo A; Garaventa A; Melioli G; Conte M
Pediatr Blood Cancer; 2013 Dec; 60(12):E170-2. PubMed ID: 23813598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]